Overview
Takeda Pharmaceuticals International SA
From aching hearts to brittle bones, if you suffer from it, Nycomed probably has a drug to help. The Swiss pharmaceutical company develops prescription and OTC medicines mainly focusing on cardiology, gastroenterology, osteoporosis, respiratory, and pain management therapies. It operates nearly 20 facilities in a dozen European countries, where it conducts its own research and drug testing. It also develops products in conjunction with partner pharmaceutical companies.
...
Read More The majority of Nycomed's revenues come from direct drug sales to doctors, hospitals, and pharmacies, as well as from licensing product rights to and from other companies. Nycomed was acquired by Japan's Takeda Pharmaceutical in 2011.
Read Less
Read More The majority of Nycomed's revenues come from direct drug sales to doctors, hospitals, and pharmacies, as well as from licensing product rights to and from other companies. Nycomed was acquired by Japan's Takeda Pharmaceutical in 2011.
Read Less
Thomas Otto Claus Wozniewski
See more contacts
Management of Companies and Enterprises
,
Holding companies, nec
Contacts
Get in Touch with 28 Principals*
-
Thomas Otto Claus WozniewskiChairman of the Board
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Data
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.